VERMOX

Registered
Word Mark

Key Information

Serial Number

Registration Number

Status

Registered

Ownership

J&

Owner Name

Type: Organization / Corporation

Address

One Johnson & Johnson Plaza
New Brunswick, NJ 08933

Critical Dates

First Use Date

Jan 1, 1971

Filing Date

Jan 11, 2016

Registration Date

Oct 14, 2025

Mark Descriptions

Goods

Class 5
Human pharmaceuticals, namely, anthelmintics

Mark Elements

Text Mark
VERMOX
Category
Trademark
Standard Characters
Yes
Color Claim
No
Data source: USPTO TSDR
View on USPTO website

Trademark Timeline

First Use

Jan 1, 1971

First Use in Commerce

Sep 9, 2021

Filing Date

Jan 11, 2016

Publication Date

Mar 29, 2022

Registration Date

Oct 14, 2025

USPTO Records

TitleDateCategorySourcePagesFormatActions

AI AssessmentCached Mar 12, 2026, 05:59 AM
Cached

AI-generated analysis of USPTO data for this trademark. WARNING: Content may not be accurate or up to date. Validate all responses.

Trademark Summary

The standard character mark VERMOX covers human pharmaceuticals, namely, anthelmintics in International Class 005, with additional domestic classes 006, 018, 044, 046, 051, and 052. It is owned by Johnson & Johnson, a New Jersey corporation based in New Brunswick. The mark is registered on the Principal Register as of October 14, 2025, under Registration Number 7985854, following conversion from an intent-to-use basis with first use in commerce on September 9, 2021.

Recent Activity

Filed on January 11, 2016, the application faced office actions, a suspension, final refusal, and an ex parte appeal instituted on February 9, 2022, which was terminated as moot on April 26, 2022, before publication for opposition on March 29, 2022. A statement of use was filed April 25, 2025, after five extensions, accepted September 19, 2025, leading to registration on October 14, 2025.
USPTO
AI Analysis
v2.8.0
Generated Mar 12, 2026, 05:59 AM

Never miss important updates for this trademark

Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.